PF
Pfizer Inc
PFE—
Pfizer Inc AI Insights
Informational only. Not investment advice.Snapshot
- Goodwill of 69.1B is 74% of equity (92.8B) - Seagen acquisition creates material impairment risk if oncology pipeline underperforms[Goodwill]
- Tangible book value is NEGATIVE (-27.6B) - equity entirely dependent on intangible assets and goodwill valuations[Tangible Book Value]
- R&D spend of 11.8B TTM (19% of revenue) vs industry median 37.6M - massive pipeline investment dwarfs peers[Research and Development]
Watch Triggers
- Free Cash Flow TTM: Falls below 8B annually — Would force dividend cut or debt increase - current 10.4B barely covers 9.8B dividend
- Goodwill: Any impairment charge announced — 69B goodwill is 74% of equity - even 10% writedown wipes 7B from book value
- Operating Margin TTM: Drops below 20% — Current 24.6% margin supports debt servicing - compression signals pricing pressure
Bull Case
PE of 11.2x vs industry median 20.2x - 45% discount prices in significant pessimism despite 62.8B revenue base and 24.6% operating margins
PE RatioOperating Margin TTMTotal Revenue TTM
FCF of 10.4B TTM (16.5% margin) supports 7.4% dividend yield while funding R&D - rare income + optionality combination
Free Cash Flow TTMDividends Paid Per Share TTMResearch and Development
Bear Case
Total debt 60.8B with negative tangible book (-27.6B) creates refinancing risk if rates stay elevated and pipeline disappoints
Total DebtTangible Book ValueInterest Expense
ROIC of 6.3% TTM on 153.6B invested capital - destroying value if WACC exceeds returns, goodwill impairment risk material
ROIC TTMInvested CapitalGoodwill
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
40%
Leverage PFE's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
FCF generation will compress as COVID revenue normalizes but debt servicing remains elevated
1-3yhigh
- Interest expense 2.7B TTM on 60.8B debt
- Net debt 59.5B vs 10.4B FCF = 5.7x coverage
- Dividend commitment 1.71/share = ~9.8B annually
Debt/equity 0.66 with negative tangible bookFCF 10.4B barely covers dividend + interestOperating CF 4.6B quarterly run-rate declining
Oncology portfolio from Seagen must deliver to justify 69B goodwill and restore growth
3-5ymed
- 120B intangibles = 58% of total assets
- Operating margin 24.6% needs pipeline success
- ROIC 6.3% TTM below cost of capital
R&D 11.8B annually for pipeline advancementPE 11.2x implies low growth expectationsIndustry median PE 20.2x shows discount
Valuation Context
Caveats
Public Strategies Rankings
See how Pfizer Inc ranks across different investment strategies.
Leverage PFE's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
PFE Fundamentals
Manufacturing → Chemical Manufacturing
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$146.56B | — | ||
$206.07B | — | ||
11 | — | ||
$62.79B | +5.7% | — | |
$2.31 | +50.8% | — | |
24.6% | +9.3% | — | |
15.7% | +8.5% | — | |
$10.38B | +26.1% | — | |
0.11 | +6.1% | — | |
Beta 5Y (Monthly) | unknown | — |
PFE Dividend History
105 dividends
2026
$0.430001/23/26$0.4300
2025
$1.720011/07/25$0.4300
07/25/25$0.4300
05/09/25$0.4300
01/24/25$0.4300
2024
$1.680011/08/24$0.4200
07/26/24$0.4200
05/09/24$0.4200
01/25/24$0.4200
2023
$1.640011/09/23$0.4100
07/27/23$0.4100
05/11/23$0.4100
01/26/23$0.4100
2022
$1.600011/03/22$0.4000
07/28/22$0.4000
05/12/22$0.4000
01/27/22$0.4000
2021
$1.560011/04/21$0.3900
07/29/21$0.3900
05/06/21$0.3900
01/28/21$0.3900
2020
$1.520011/05/20$0.3800
07/30/20$0.3800
05/07/20$0.3800
01/30/20$0.3800
2019
$1.440011/07/19$0.3600
08/01/19$0.3600
05/09/19$0.3600
01/31/19$0.3600
2018
$1.360011/08/18$0.3400
08/02/18$0.3400
05/10/18$0.3400
02/01/18$0.3400
2017
$1.280011/09/17$0.3200
08/02/17$0.3200
05/10/17$0.3200
02/01/17$0.3200
2016
$1.200011/08/16$0.3000
08/03/16$0.3000
05/11/16$0.3000
02/03/16$0.3000
2015
$1.120011/04/15$0.2800
08/05/15$0.2800
05/06/15$0.2800
02/04/15$0.2800
2014
$1.040011/05/14$0.2600
07/30/14$0.2600
05/07/14$0.2600
02/05/14$0.2600
2013
$0.960011/06/13$0.2400
07/31/13$0.2400
05/08/13$0.2400
01/30/13$0.2400
2012
$0.880011/07/12$0.2200
08/01/12$0.2200
05/09/12$0.2200
02/01/12$0.2200
2011
$0.800011/08/11$0.2000
08/03/11$0.2000
05/11/11$0.2000
02/02/11$0.2000
2010
$0.720011/04/10$0.1800
08/04/10$0.1800
05/05/10$0.1800
02/03/10$0.1800
2009
$0.800011/04/09$0.1600
08/05/09$0.1600
05/06/09$0.1600
02/04/09$0.3200
2008
$1.280011/05/08$0.3200
08/06/08$0.3200
05/07/08$0.3200
02/06/08$0.3200
2007
$1.160011/07/07$0.2900
08/08/07$0.2900
05/09/07$0.2900
02/07/07$0.2900
2006
$0.960011/08/06$0.2400
08/09/06$0.2400
05/10/06$0.2400
02/08/06$0.2400
2005
$0.760011/08/05$0.1900
08/10/05$0.1900
05/11/05$0.1900
02/09/05$0.1900
2004
$0.680011/09/04$0.1700
08/11/04$0.1700
05/12/04$0.1700
02/11/04$0.1700
2003
$0.600011/12/03$0.1500
08/13/03$0.1500
05/14/03$0.1500
01/15/03$0.1500
2002
$0.520011/13/02$0.1300
08/14/02$0.1300
05/15/02$0.1300
02/13/02$0.1300
2001
$0.440011/14/01$0.1100
08/15/01$0.1100
05/16/01$0.1100
02/14/01$0.1100
2000
$0.360011/15/00$0.0900
08/16/00$0.0900
05/09/00$0.0900
02/16/00$0.0900
PFE Stock Splits
No stock splits
PFE SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/04/25 | 09/28/25 | 10-Q | |
08/05/25 | 06/29/25 | 10-Q | |
05/05/25 | 03/30/25 | 10-Q | |
02/27/25 | 12/31/24 | 10-K | |
11/04/24 | 09/29/24 | 10-Q | |
08/05/24 | 06/30/24 | 10-Q | |
05/08/24 | 03/31/24 | 10-Q | |
02/22/24 | 12/31/23 | 10-K | |
11/08/23 | 10/01/23 | 10-Q | |
08/09/23 | 07/02/23 | 10-Q | |
05/10/23 | 04/02/23 | 10-Q | |
02/23/23 | 12/31/22 | 10-K | |
11/09/22 | 10/02/22 | 10-Q | |
08/10/22 | 07/03/22 | 10-Q | |
05/11/22 | 04/03/22 | 10-Q | |
02/24/22 | 12/31/21 | 10-K | |
11/12/21 | 10/03/21 | 10-Q | |
08/12/21 | 07/04/21 | 10-Q | |
05/13/21 | 04/04/21 | 10-Q | |
02/25/21 | 12/31/20 | 10-K | |
11/05/20 | 09/27/20 | 10-Q | |
08/06/20 | 06/28/20 | 10-Q | |
05/07/20 | 03/29/20 | 10-Q | |
02/27/20 | 12/31/19 | 10-K | |
11/07/19 | 09/29/19 | 10-Q | |
08/08/19 | 06/30/19 | 10-Q | |
05/09/19 | 03/31/19 | 10-Q | |
02/28/19 | 12/31/18 | 10-K | |
11/08/18 | 09/30/18 | 10-Q | |
08/09/18 | 07/01/18 | 10-Q | |
05/10/18 | 04/01/18 | 10-Q | |
02/22/18 | 12/31/17 | 10-K | |
11/09/17 | 10/01/17 | 10-Q | |
08/10/17 | 07/02/17 | 10-Q | |
05/11/17 | 04/02/17 | 10-Q | |
02/23/17 | 12/31/16 | 10-K | |
11/10/16 | 10/02/16 | 10-Q | |
08/11/16 | 07/03/16 | 10-Q | |
05/12/16 | 04/03/16 | 10-Q | |
02/29/16 | 12/31/15 | 10-K | |
11/05/15 | 09/27/15 | 10-Q | |
08/06/15 | 06/28/15 | 10-Q | |
05/07/15 | 03/29/15 | 10-Q | |
02/27/15 | 12/31/14 | 10-K | |
11/06/14 | 09/28/14 | 10-Q | |
08/07/14 | 06/29/14 | 10-Q | |
05/08/14 | 03/30/14 | 10-Q | |
02/28/14 | 12/31/13 | 10-K | |
11/08/13 | 09/29/13 | 10-Q | |
08/09/13 | 06/30/13 | 10-Q | |
05/10/13 | 03/31/13 | 10-Q | |
02/28/13 | 12/31/12 | 10-K | |
11/09/12 | 09/30/12 | 10-Q | |
08/09/12 | 07/01/12 | 10-Q | |
05/10/12 | 04/01/12 | 10-Q | |
02/28/12 | 12/31/11 | 10-K | |
11/10/11 | 10/02/11 | 10-Q | |
08/11/11 | 07/03/11 | 10-Q | |
05/12/11 | 04/03/11 | 10-Q | |
02/28/11 | 12/31/10 | 10-K | |
11/12/10 | 10/03/10 | 10-Q | |
08/12/10 | 07/04/10 | 10-Q | |
05/13/10 | 04/04/10 | 10-Q | |
02/26/10 | 12/31/09 | 10-K | |
11/05/09 | 09/27/09 | 10-Q | |
08/06/09 | 06/28/09 | 10-Q | |
05/08/09 | 03/29/09 | 10-Q | |
02/27/09 | 12/31/08 | 10-K | |
11/07/08 | 09/30/08 | 8-K | |
08/08/08 | 06/30/08 | Unknown | -- |
05/02/08 | 03/31/08 | 10-Q | |
02/29/08 | 12/31/07 | 10-K | |
11/05/07 | 09/30/07 | 10-Q | |
08/06/07 | 06/30/07 | Unknown | -- |
05/04/07 | 03/30/07 | Unknown | -- |
03/01/07 | 12/31/06 | 10-K | |
11/03/06 | 09/30/06 | Unknown | -- |
08/11/06 | 06/30/06 | Unknown | -- |
05/08/06 | 03/30/06 | Unknown | -- |
03/01/06 | 12/31/05 | 10-K | |
11/09/05 | 09/30/05 | Unknown | -- |
08/08/05 | 06/30/05 | Unknown | -- |
05/06/05 | 03/30/05 | Unknown | -- |
02/28/05 | 12/31/04 | 8-K | |
11/05/04 | 09/30/04 | Unknown | -- |
08/06/04 | 06/30/04 | Unknown | -- |
05/07/04 | 03/30/04 | Unknown | -- |
03/10/04 | 12/31/03 | 10-K | |
11/12/03 | 09/30/03 | 4 | |
08/13/03 | 06/30/03 | Unknown | -- |
05/14/03 | 03/31/03 | 10-Q | |
03/27/03 | 12/31/02 | 4 | |
11/13/02 | 09/30/02 | Unknown | -- |
08/13/02 | 06/30/02 | 10-Q | |
05/15/02 | 03/30/02 | Unknown | -- |
03/28/02 | 12/31/01 | ARS | |
11/13/01 | 09/30/01 | 10-Q | |
08/14/01 | 06/30/01 | Unknown | -- |
05/15/01 | 03/30/01 | Unknown | -- |
03/28/01 | 12/31/00 | 10-K405 | |
11/15/00 | 09/30/00 | Unknown | -- |
08/15/00 | 06/30/00 | Unknown | -- |
05/17/00 | 03/30/00 | Unknown | -- |